Interview With Prof. Kausik Ray - Latest Study On Fh Prevalence Globally May 2020

Interview with Prof. Kausik Ray - latest study on FH prevalence globally May 2020

FH Europe Foundation

ESC 2015: PCSK9 a ‘game changer’ in the treatment of familial hypercholesterolaemia - Prof K Ray

WHF Roadmap for Cholesterol | Prof Kausik Ray

Prof Kausik Ray: How will FOURIER impact FH care?

Results of BETonMACE with Kausik Ray

Professor Kausik Ray - The global burden of diabetes.

At the Limits - Leading Medical Education

Prof. Kausik Ray: Late Breaking Session at EAS Congress 2019

EAS - The European Atherosclerosis Society

New findings from the ORION-11 study - Professor Kausik K. Ray

EAS - The European Atherosclerosis Society

Kausik Ray about the EAS FH studies collaboration

EAS - The European Atherosclerosis Society

AHA 2019 : Results Of The BETonMACE Trial — Prof Kausik K Ray

Radcliffe Cardiology

Hear from Prof. Kaushik Ray on his thoughts on EDEC 2023

MCI Middle East

Is Inflammation the "real cause" of Heart Disease? | Prof. Kausik Ray

Nutrition Made Simple!

Kausik Ray UK Familial Hypercholesterolemia What Is It How Do We Find It And Manage It

Late Breaking News ORION-1, Professor Kausik Ray

EAS - The European Atherosclerosis Society

EASD 2017 - Kosh Ray Interview

Touch Medical Media

Residual cardiovascular risk a role for PCSK9 inhibition | Professor Kausik Ray

ESC 2018: CLEAR Harmony - Prof Kausik Ray

Radcliffe Cardiology

Kausik Ray: The ODYSSEY Insulin Trials

Efficacy and Safety of Alirocumab in Patients with Diabetes at EASD 2017

Radcliffe Cardiology

Prof Kausik Ray discusses the ORION 1 study with inclisiran